BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18723356)

  • 61. Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc.
    Huang CY; Stauffer TM; Strickland CL; Reader JC; Huang H; Li G; Cooper AB; Doll RJ; Ganguly AK; Baldwin JJ; Rokosz LL
    Bioorg Med Chem Lett; 2006 Feb; 16(3):507-11. PubMed ID: 16289818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitors designed for the active site of dihydroorotase.
    Li Y; Raushel FM
    Bioorg Chem; 2005 Dec; 33(6):470-83. PubMed ID: 16213543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
    Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
    Tang H; Wei YB; Zhang C; Ning FX; Qiao W; Huang SL; Ma L; Huang ZS; Gu LQ
    Eur J Med Chem; 2009 Jun; 44(6):2523-32. PubMed ID: 19243862
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bioactivity of glycogen phosphorylase inhibitors that bind to the purine nucleoside site.
    Hampson LJ; Arden C; Agius L; Ganotidis M; Kosmopoulou MN; Tiraidis C; Elemes Y; Sakarellos C; Leonidas DD; Oikonomakos NG
    Bioorg Med Chem; 2006 Dec; 14(23):7835-45. PubMed ID: 16908161
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase.
    Czifrák K; Hadady Z; Docsa T; Gergely P; Schmidt J; Wessjohann L; Somsák L
    Carbohydr Res; 2006 Jun; 341(8):947-56. PubMed ID: 16564511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.
    Bello AM; Konforte D; Poduch E; Furlonger C; Wei L; Liu Y; Lewis M; Pai EF; Paige CJ; Kotra LP
    J Med Chem; 2009 Mar; 52(6):1648-58. PubMed ID: 19260677
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beta-lactam congeners of orlistat as inhibitors of fatty acid synthase.
    Zhang W; Richardson RD; Chamni S; Smith JW; Romo D
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2491-4. PubMed ID: 18343106
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists.
    Motoshima K; Ishikawa M; Sugita K; Hashimoto Y
    Biol Pharm Bull; 2009 Sep; 32(9):1618-20. PubMed ID: 19721243
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and evaluation of some novel isochroman carboxylic acid derivatives as potential anti-diabetic agents.
    Lakshminarayana N; Rajendra Prasad Y; Gharat L; Thomas A; Ravikumar P; Narayanan S; Srinivasan CV; Gopalan B
    Eur J Med Chem; 2009 Aug; 44(8):3147-57. PubMed ID: 19349096
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.
    Rath VL; Ammirati M; Danley DE; Ekstrom JL; Gibbs EM; Hynes TR; Mathiowetz AM; McPherson RK; Olson TV; Treadway JL; Hoover DJ
    Chem Biol; 2000 Sep; 7(9):677-82. PubMed ID: 10980448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase.
    Zhang P; Hao J; Liu J; Lu Q; Sheng H; Zhang L; Sun H
    J Nat Prod; 2009 Aug; 72(8):1414-8. PubMed ID: 19642687
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
    Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
    Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors.
    Liu Y; Zou L; Ma L; Chen WH; Wang B; Xu ZL
    Bioorg Med Chem; 2006 Aug; 14(16):5683-90. PubMed ID: 16651002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents.
    Deninno MP; Andrews M; Bell AS; Chen Y; Eller-Zarbo C; Eshelby N; Etienne JB; Moore DE; Palmer MJ; Visser MS; Yu LJ; Zavadoski WJ; Michael Gibbs E
    Bioorg Med Chem Lett; 2009 May; 19(9):2537-41. PubMed ID: 19339180
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure-activity relationships of pyrazine-based CK2 inhibitors: synthesis and evaluation of 2,6-disubstituted pyrazines and 4,6-disubstituted pyrimidines.
    Suzuki Y; Cluzeau J; Hara T; Hirasawa A; Tsujimoto G; Oishi S; Ohno H; Fujii N
    Arch Pharm (Weinheim); 2008 Sep; 341(9):554-61. PubMed ID: 18763715
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate.
    Beck J; Vercheval L; Bebrone C; Herteg-Fernea A; Lassaux P; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3593-7. PubMed ID: 19467869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase.
    Kato A; Nasu N; Takebayashi K; Adachi I; Minami Y; Sanae F; Asano N; Watson AA; Nash RJ
    J Agric Food Chem; 2008 Jun; 56(12):4469-73. PubMed ID: 18494482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.